المؤلفون: M Franken, B Leeneman, M.J.B. Aarts, FWPJ van den Berkmortel, CU Blank, MJ Boers-Sonderen, AJM van den Eertwegh, JWB de Groot, JBAG Haanen, GAP Hospers, E Kapiteijn, OJ van Not, D Piersma, RS van Rijn, MAM Stevense-den Boer, KPM Suijkerbuijk, AAM van der Veldt, G Vreugdenhil, MWJM Wouters, A van Dongen, CA Uyl-De Groot

المصدر: Value in Health. 25:S230-S231

مصطلحات موضوعية: Health Policy, Public Health, Environmental and Occupational Health

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::3b7a342b27bed666d4eae7be6d790d12
https://doi.org/10.1016/j.jval.2021.11.1128

المؤلفون: M Franken, S de Groot, A van Dongen, B Leeneman, CA Uyl-De Groot, MJB Aarts, FWPJ van den Berkmortel, CU Blank, MJ Boers-Sonderen, AJM van den Eertwegh, JWB de Groot, JBAG Haanen, GAP Hospers, E Kapiteijn, OJ van Not, D Piersma, RS van Rijn, MAM Stevense-den Boer, KPM Suijkerbuijk, AAM van der Veldt, G Vreugdenhil, MWJM Wouters, M Versteegh, HM Blommestein

المصدر: Value in Health. 25:S243-S244

مصطلحات موضوعية: Health Policy, Public Health, Environmental and Occupational Health

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7fa0d23c0ccad3dded9f088b503f6b3d
https://doi.org/10.1016/j.jval.2021.11.1190

المؤلفون: S de Groot, HM Blommestein, B Leeneman, Groot CA Uyl-De, JBAG Haanen, KPM Suijkerbuijk, M.J.B. Aarts, FWPJ van den Berkmortel, CU Blank, MJ Boers-Sonderen, AJM van den Eertwegh, JWB de Groot, GAP Hospers, E Kapiteijn, MM de Meza, D Piersma, RS van Rijn, MAM Stevense-den Boer, AAM van der Veldt, G Vreugdenhil, MWJM Wouters, M Franken, PHM van Baal

المصدر: Value in Health. 25:S16

مصطلحات موضوعية: Health Policy, Public Health, Environmental and Occupational Health

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::1239c668de8deef62c04b637c6b27370
https://doi.org/10.1016/j.jval.2021.11.069

المؤلفون: M Franken, A van Dongen, B Leeneman, CA Uyl-De Groot, MJB Aarts, FWPJ van den Berkmortel, CU Blank, MJ Boers-Sonderen, AJM van den Eertwegh, JWB de Groot, JBAG Haanen, GAP Hospers, E Kapiteijn, MM de Meza, D Piersma, RS van Rijn, MAM Stevense-den Boer, KPM Suijkerbuijk, AAM van der Veldt, G Vreugdenhil, MWJM Wouters, HM Blommestein, M Versteegh

المصدر: Value in Health. 25:S244

مصطلحات موضوعية: Health Policy, Public Health, Environmental and Occupational Health

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::1cb44505452289d62a73af32c48d12fc
https://doi.org/10.1016/j.jval.2021.11.1191

المؤلفون: van Not OJ; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, the Netherlands.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Jalving H; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Bloem M; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, the Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Haanen JB; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van Rijn RS; Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden, the Netherlands., Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands., van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Center Sittard, Sittard-Geleen, the Netherlands., Blank CU; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., de Groot J W B JW; Isala Oncology Center, Isala, Zwolle, the Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Leeneman B; Department of Health Technology Assessment, Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, the Netherlands.; Erasmus Center for Health Economics Rotterdam, Erasmus University Rotterdam, Rotterdam, the Netherlands., D P; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, the Netherlands., Stevense-den Boer M; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands., van der Veldt AAM; Department of Medical Oncology and Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, the Netherlands., Vreugdenhil G G; Department of Internal Medicine, Maxima Medical Center, Eindhoven, the Netherlands., Wouters MWJM; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, the Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Blokx WAM; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

المصدر: JAMA network open [JAMA Netw Open] 2024 Aug 01; Vol. 7 (8), pp. e2426641. Date of Electronic Publication: 2024 Aug 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/drug therapy , Melanoma*/mortality , Immune Checkpoint Inhibitors*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Aged ; Netherlands/epidemiology ; Ipilimumab/therapeutic use ; Nivolumab/therapeutic use ; Skin Neoplasms/drug therapy ; Skin Neoplasms/mortality ; Skin Neoplasms/pathology ; Cohort Studies ; Registries ; Progression-Free Survival ; Prospective Studies

المؤلفون: Rauwerdink DJW; Department of Dermatology, Leiden University Medical Center, Leiden University, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands., Not OV; Department of Dermatology, Leiden University Medical Center, Leiden University, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands.; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, 2333 AA Leiden, The Netherlands., de Meza M; Department of Ear-Nose-Throat ENT, Leiden University Medical Center, Leiden University, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands., Doorn RV; Department of Dermatology, Leiden University Medical Center, Leiden University, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands., Hage JV; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Eertwegh AJMVD; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, 1081 HZ Amsterdam, The Netherlands., Haanen JB; Department of Medical Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands., Berkmortel FWPJVD; Department of Medical Oncology, Zuyderland Medical Centre Sittard, Dr. H. van der Hoffplein 1, 6162 BG Sittard-Geleen, The Netherlands., Blank CU; Department of Medical Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands., Groot JWB; Isala Oncology Center, Isala, Dokter van Heesweg 2, 8025 AB Zwolle, The Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands., Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Koningsplein 1, 7512 KZ Enschede, The Netherlands., van Rijn RS; Department of Internal Medicine, Medical Centre Leeuwarden, Henri Dunantweg 2, 8934 AD Leeuwarden, The Netherlands., Stevense-den Boer AM; Department of Internal Medicine, Amphia Hospital, Molengracht 21, 4818 CK Breda, The Netherlands., Veldt AAMV; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Centre, 's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands., Vreugdenhil G; Department of Internal Medicine, Maxima Medical Centre, De Run 4600, 5504 DB Eindhoven, The Netherlands., Wouters MWJM; Scientific Bureau, Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, 2333 AA Leiden, The Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Einthovenweg 20, 2333 ZC Leiden, The Netherlands., Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.

المصدر: Cancers [Cancers (Basel)] 2024 Jul 26; Vol. 16 (15). Date of Electronic Publication: 2024 Jul 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: De Jonge AV; Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam., Bruins WSC; Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam., Duetz C; Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam., Korst CLBM; Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam., Rentenaar R; Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam., Cosovic M; Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam., Eken M; Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam., Kersten MJ; Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam., Sandberg Y; Department of Internal Medicine, Maasstad Hospital, Rotterdam., Van Rijn RS; Department of Internal Medicine, Medisch Centrum Leeuwarden, Leeuwarden., Fijnheer R; Department of Internal Medicine, Meander Medisch Centrum, Amersfoort., Mutsaers P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam., Vergote VKJ; Department of Hematology, University Hospitals Leuven, Leuven., Issa D; Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch., Beeker A; Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp., Bilgin YM; Department of Internal Medicine, Adrz, Goes., Visser O; Department of Internal medicine, Isala, Zwolle., Van Werkhoven E; HOVON foundation, Rotterdam, The Netherlands; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam., Roemer MGM; Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam., Chamuleau MED; Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam., Mutis T; Department of Hematology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam. t.mutis@amsterdamumc.nl.

المصدر: Haematologica [Haematologica] 2024 Jul 04. Date of Electronic Publication: 2024 Jul 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

المؤلفون: Bloem M; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Not OJ; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands., van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Centre Sittard, Sittard-Geleen, The Netherlands., Blank CU; Department of Medical Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Blokx WAM; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Bonenkamp JJ; Department of Surgery, Radboud University Medical Centre, Nijmegen, The Netherlands., de Groot JB; Isala Oncology Center, Zwolle, The Netherlands., Haanen JB; Department of Medical Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Kapiteijn EW; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands., de Meza MM; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, The Netherlands., van Rijn RS; Department of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden, The Netherlands., Stevense-den Boer MAM; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands., van der Veldt AAM; Department of Medical Oncology, Erasmus Medical Centre, Rotterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands., Vreugdenhil G; Department of Internal Medicine, Maxima Medical Centre, Eindhoven, The Netherlands., van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Wouters MWJM; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

المصدر: International journal of cancer [Int J Cancer] 2024 Oct 15; Vol. 155 (8), pp. 1455-1465. Date of Electronic Publication: 2024 Jun 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/drug therapy , Melanoma*/genetics , Melanoma*/mortality , Melanoma*/pathology , Immune Checkpoint Inhibitors*/therapeutic use , Skin Neoplasms*/drug therapy , Skin Neoplasms*/pathology , Skin Neoplasms*/genetics , Skin Neoplasms*/mortality, Humans ; Male ; Female ; Middle Aged ; Aged ; Chemotherapy, Adjuvant/methods ; Prospective Studies ; Adult ; Mutation ; Netherlands/epidemiology ; Aged, 80 and over ; Melanoma, Cutaneous Malignant ; Registries ; Programmed Cell Death 1 Receptor/antagonists & inhibitors

المؤلفون: van Duin IAJ; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Verheijden RJ; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van Diest PJ; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Blokx WAM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., El-Sharouni MA; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Verhoeff JJC; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Leiner T; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA., van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., de Groot JWB; Isala Oncology Center, Zwolle, The Netherlands., van Not OJ; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands., Aarts MJB; Department of Medical Oncology, GROW-School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands., van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Centre Sittard, Sittard-Geleen, The Netherlands., Blank CU; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Haanen JBAG; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, The Netherlands., van Rijn RS; Department of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden, The Netherlands., van der Veldt AAM; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands., Vreugdenhil G; Department of Internal Medicine, Maxima Medical Centre, Eindhoven, The Netherlands., Wouters MWJM; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Stevense-den Boer MAM; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands., Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands., Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Elias SG; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

المصدر: International journal of cancer [Int J Cancer] 2024 May 15; Vol. 154 (10), pp. 1760-1771. Date of Electronic Publication: 2024 Jan 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/pathology , Skin Neoplasms*/pathology, Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Ipilimumab/therapeutic use ; Nivolumab/therapeutic use ; Retrospective Studies

المؤلفون: Van Not OJ; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands., van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Haanen JB; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van Rijn RS; Department of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden, The Netherlands., Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands., van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Centre Sittard, Sittard-Geleen, The Netherlands., Blank CU; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., de Groot JWWB; Isala Oncology Center, Zwolle, The Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands., Bloem M; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Piersma D; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, The Netherlands., Stevense-den Boer M; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands., Verheijden RJ; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands., van der Veldt AAM; Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands., Wouters MWJM; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, The Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Blokx WAM; Department of Pathology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands., Suijkerbuijk KPM; Department of Medical Oncology, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.

المصدر: Cancer [Cancer] 2024 May 01; Vol. 130 (9), pp. 1673-1683. Date of Electronic Publication: 2024 Jan 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms*/etiology , Brain Neoplasms*/pathology , Melanoma*/drug therapy , Melanoma*/pathology, Humans ; Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors ; Mutation ; Protein Kinase Inhibitors/therapeutic use ; Proto-Oncogene Proteins B-raf/antagonists & inhibitors ; Retrospective Studies